Seizure Control for Brain Tumor
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how seizures change over time in people with low-grade gliomas (a type of brain tumor) and their treatments. By tracking these seizures, the researchers hope to identify symptoms or triggers earlier, potentially leading to quicker and better care. Participants will complete a brief survey about their seizures during each clinic visit. This trial might suit adults with primary brain tumors who have a history of seizures related to their tumor and are currently receiving treatment. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important findings.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores seizure control as a novel metric for evaluating the effectiveness of tumor treatments in patients with low-grade glioma. Unlike traditional methods that primarily focus on tumor size changes, this approach emphasizes the impact on seizure activity, which is a significant concern for patients. By using a simple, quick survey that patients complete during clinic visits, this method aims to provide a more patient-centered evaluation of treatment success, potentially leading to more personalized and effective care strategies.
Who Is on the Research Team?
Ashley Aaroe, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Observational
Patients complete a seizure assessment survey over 5 minutes at each clinic visit
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Survey Administration
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator